Inflammatory Control is the clinical objective of actively managing and minimizing chronic, low-grade systemic inflammation, often referred to as “inflammaging,” which is a key driver of hormonal dysfunction and age-related disease. This control is achieved by balancing pro-inflammatory cytokines with anti-inflammatory mediators to maintain tissue homeostasis. Effective control is essential for protecting endocrine glands and hormone receptor sites.
Origin
The concept is central to modern immunology and chronic disease pathology, recognizing chronic inflammation as a unifying mechanism in conditions from cardiovascular disease to metabolic syndrome. In endocrinology, the term is critical because inflammation directly impairs insulin signaling, suppresses thyroid function, and alters the metabolism of steroid hormones.
Mechanism
The mechanism of Inflammatory Control involves targeted interventions that regulate the nuclear factor kappa B (NF-κB) pathway and other inflammatory transcription factors. Strategies include optimizing the omega-6 to omega-3 fatty acid ratio, improving gut barrier function to reduce endotoxin leakage, and utilizing specific nutrients or compounds that modulate cytokine production. The goal is to reduce the systemic inflammatory burden, thereby preserving cellular function and hormonal sensitivity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.